FDA approves Dilons lesion-localization system

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

The FDA has granted 510(k) clearance for Dilon Diagnostics’ lesion-localization system for molecular imaging biopsy guidance.

The GammaLMc, a complementary technology to the Dilon 6800 Gamma Camera, is a system to help doctors locate breast lesions and allow gamma-guided biopsies, according to the Newport News, Va.-based company.  The GammaLMc system utilizes a CorreLocator paddle and a StereoView imaging collimator system—a technique similar to that used in stereotactic x-ray localization—and the GammaLMc software calculates the location of the lesion.